|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Minnesota Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MinnesotaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Cardiovascular Systems, Inc.
| | | Phone: | (651) 259-1600 | Fax: | (651) 677-3355 | Year Established: | 1989 | Ticker: | CSII | Exchange: | NASDAQ | Main Contact: | David L. Martin, President & CEO | | Other Contacts: | Robert J. Thatcher, Chief Healthcare Policy Officer Paul Koehn, Senior VP, Quality & Operations Rhonda Robb, COO Jeff Points, CFO
| | Company Description | Cardiovascular Systems (CSI) is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital Atherectomy System in peripheral arteries in August 2007. In October 2013, the company received FDA approval for the use of the Diamondback Orbital Atherectomy System in coronary arteries. | |
|
|
|
|
|